Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.
作者信息
Andreani Marco, Testi Manuela, Sodani Pietro, Troiano Maria, Di Luzio Andrea, Testa Giuseppe, Falco Michela, Poggi Elvira, Gaziev Javid, Piazza Antonina
机构信息
Laboratory of Immunogenetics and Transplant Biology, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy.
International Center for Transplantation in Thalassemia and Sickle Cell Anemia, IME Foundation at Polyclinic of Tor Vergata, Rome, Italy.
出版信息
Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017020. doi: 10.4084/MJHID.2017.020. eCollection 2017.
Abstract
摘要
相似文献
1
Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia.供者特异性抗HLA抗体和供者杀伤细胞免疫球蛋白样受体特征对β地中海贫血单倍体造血干细胞移植的影响
Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017020. doi: 10.4084/MJHID.2017.020. eCollection 2017.
2
[Impact of donor KIR2DS5 genotype on outcome following haploidentical hematopoietic stem cell transplantation].[供者KIR2DS5基因型对单倍体相合造血干细胞移植后结局的影响]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):111-5.
3
[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].杀伤细胞免疫球蛋白样受体及人类白细胞抗原I类配体对相关供者造血干细胞移植预后的影响
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):533-7.
4
5
Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.不相容的杀伤细胞免疫球蛋白样受体及其配体对单倍体相合骨髓移植结局的影响。
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):809-15.
6
Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.供者和受者共表达 KIR 配体可促进异基因造血干细胞移植后 NK 细胞的教育。
Blood Adv. 2019 Dec 23;3(24):4312-4325. doi: 10.1182/bloodadvances.2019000242.
7
Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection.基于杀伤细胞免疫球蛋白样受体（KIR）的移植物选择降低无关供体干细胞移植后的复发率
Front Immunol. 2017 Feb 8;8:41. doi: 10.3389/fimmu.2017.00041. eCollection 2017.
8
[Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].[预先存在的供者特异性HLA抗体对非预处理单倍体相合造血干细胞移植中移植物失败的影响]
Zhonghua Xue Ye Xue Za Zhi. 2018 Mar 14;39(3):190-195. doi: 10.3760/cma.j.issn.0253-2727.2018.03.004.
9
KIR/HLA-I mismatching and risk of relapse in paediatric patients undergoing non-haploidentical allogeneic haematopoietic stem cell transplantation.儿童非单倍体相合异基因造血干细胞移植中KIR/HLA-I错配与复发风险
Pediatr Transplant. 2011 Mar;15(2):198-204. doi: 10.1111/j.1399-3046.2010.01447.x.
10
Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.单倍体相合造血干细胞移植治疗费城染色体阳性急性淋巴细胞白血病的良好结局：中国西南部多中心研究
J Hematol Oncol. 2015 Jul 26;8:90. doi: 10.1186/s13045-015-0186-5.
引用本文的文献
1
A Single Centre Experience of Effective Desensitization Strategy for Children with High Anti-HLA Donor-Specific Antibodies Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.单中心对具有高抗人白细胞抗原供者特异性抗体的儿童进行单倍体造血干细胞移植时有效脱敏策略的经验。
Indian J Hematol Blood Transfus. 2024 Apr;40(2):335-339. doi: 10.1007/s12288-023-01661-2. Epub 2023 Jun 20.
2
Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen.基于 FBCA 预处理方案的重型地中海贫血的单倍体造血干细胞移植。
Br J Haematol. 2018 Aug;182(4):554-558. doi: 10.1111/bjh.15438. Epub 2018 Jul 1.
3
Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.主要组织相容性复合体与造血干细胞移植：超越经典 HLA 多态性。
Int J Mol Sci. 2018 Feb 22;19(2):621. doi: 10.3390/ijms19020621.
4
Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ/CD19-depleted grafts.针对血红蛋白病的单倍体 HSCT：TCRαβ/CD19 耗尽的移植物可改善结局。
Blood Adv. 2018 Feb 13;2(3):263-270. doi: 10.1182/bloodadvances.2017012005.
本文引用的文献
1
What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics.地中海贫血的无关造血干细胞移植让我们了解到的移植免疫遗传学
Mediterr J Hematol Infect Dis. 2016 Oct 20;8(1):e2016048. doi: 10.4084/MJHID.2016.048. eCollection 2016.
2
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植中的供者特异性抗HLA抗体
Front Immunol. 2016 Aug 12;7:307. doi: 10.3389/fimmu.2016.00307. eCollection 2016.
3
Transplantation for thalassemia major: alternative donors.重型地中海贫血的移植：替代供者
Curr Opin Hematol. 2016 Nov;23(6):515-523. doi: 10.1097/MOH.0000000000000280.
4
Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.用于人类白细胞抗原半相合造血干细胞移植的αβ T细胞和B细胞的选择性清除。该操作效率的三年随访
Biol Blood Marrow Transplant. 2016 Nov;22(11):2056-2064. doi: 10.1016/j.bbmt.2016.08.006. Epub 2016 Aug 9.
5
Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets.供者特异性抗人白细胞抗原抗体与未处理的单倍体相合造血干细胞移植后的原发性移植物功能衰竭相关：一项采用随机分配训练集和验证集的前瞻性研究。
J Hematol Oncol. 2015 Jul 10;8:84. doi: 10.1186/s13045-015-0182-9.
6
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update.清髓性预处理后非处理单倍体相合骨髓移植及移植后环磷酰胺治疗血液系统恶性肿瘤：最新进展
Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S37-9. doi: 10.1038/bmt.2015.93.
7
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.KIR 配体错配供者的单倍体造血移植伴有激活型 KIR 可降低非复发死亡率。
Blood. 2015 May 14;125(20):3173-82. doi: 10.1182/blood-2014-09-599993. Epub 2015 Mar 13.
8
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders.HLA 单倍体相合干细胞移植后去除αβ+T 和 B 细胞在非恶性疾病患儿中的应用。
Blood. 2014 Jul 31;124(5):822-6. doi: 10.1182/blood-2014-03-563817. Epub 2014 May 28.
9
KIR and KIR ligand polymorphism: a new area for clinical applications?杀伤细胞免疫球蛋白样受体（KIR）及其配体多态性：临床应用的新领域？
Tissue Antigens. 2013 Dec;82(6):363-73. doi: 10.1111/tan.12262.
10
Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach.从其他相关供体进行地中海贫血的骨髓移植：新方法改善了结果。
Blood. 2013 Oct 10;122(15):2751-6. doi: 10.1182/blood-2013-07-513473. Epub 2013 Aug 20.
Zotero 插件